Konstantinos Voumvourakis Selected Research

Antibodies

8/2023	Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination.
6/2014	Double seropositive myasthenia gravis with acetylcholine receptor and lipoprotein receptor-related protein 4 antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Konstantinos Voumvourakis Research Topics

Disease

14	Ischemic Stroke 03/2024 - 11/2011
11	Stroke (Strokes) 12/2021 - 11/2011
6	Multiple Sclerosis 02/2022 - 01/2016
3	Inflammation (Inflammations) 11/2022 - 01/2021
3	Atherosclerosis 12/2021 - 03/2016
3	Atrial Fibrillation 05/2017 - 05/2014
3	Transient Ischemic Attack 01/2017 - 05/2014
3	Relapsing-Remitting Multiple Sclerosis 01/2016 - 01/2015
2	Psychotic Disorders (Schizoaffective Disorder) 12/2023 - 01/2023
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 08/2023 - 01/2021
2	Neuromyelitis Optica (Devic's Disease) 08/2023 - 01/2014
2	Myasthenia Gravis 01/2023 - 06/2014
2	Neurologic Manifestations (Neurological Manifestations) 02/2022 - 01/2022
2	Nervous System Diseases (Neurological Disorders) 02/2022 - 01/2017
2	Hemorrhagic Stroke 01/2021 - 09/2016
2	Brain Ischemia (Cerebral Ischemia) 01/2017 - 09/2016
2	Hemorrhage 09/2016 - 05/2014
2	Atrophy 09/2015 - 01/2015
2	Disease Progression 01/2015 - 07/2005
2	Hypertension (High Blood Pressure) 05/2014 - 05/2013
1	Tremor (Tremors) 12/2023
1	Demyelinating Diseases (Demyelinating Disease) 08/2023
1	Muscle Weakness 01/2023
1	Guillain-Barre Syndrome 02/2022
1	Encephalomyelitis (Myeloencephalitis) 02/2022
1	Atherosclerotic Plaque (Atheroma) 12/2021
1	Cerebral Small Vessel Diseases 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Foreign-Body Reaction 01/2021
1	Pulmonary Arterial Hypertension 01/2020
1	Hyperglycemia 09/2019
1	Hypoglycemia (Reactive Hypoglycemia) 09/2019
1	Vasculitis (Vasculitides) 11/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2017
1	Cerebral Hemorrhage 01/2017
1	Patent Foramen Ovale 09/2016
1	Hyperemia 01/2016
1	Venous Insufficiency 01/2016
1	Cognitive Dysfunction 08/2015
1	Hypothyroidism 08/2015
1	Necrosis 07/2015
1	Hydrocephalus (Hydrocephaly) 01/2015
1	Thrombosis (Thrombus) 01/2015

Drug/Important Bio-Agent (IBA)

3	Amyloid (Amyloid Fibrils)IBA 08/2023 - 01/2021
3	AutoantibodiesIBA 01/2023 - 01/2022
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2022 - 03/2016
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2017
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 04/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2014
3	InterferonsIBA 01/2020 - 10/2017
2	antineoplaston A10 (A 10)IBA 12/2023 - 01/2023
2	AntibodiesIBA 08/2023 - 06/2014
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 11/2018 - 06/2014
2	Dabigatran FDA Link 09/2016 - 05/2014
2	mesoglycanIBA 09/2015 - 11/2014
2	EnzymesIBA 08/2015 - 09/2010
2	Adenosine Triphosphatases (ATPase)IBA 08/2015 - 09/2013
1	muskIBA 01/2023
1	neonatal Fc receptorIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	AntigensIBA 01/2023
1	Genetic Markers (Genetic Marker)IBA 11/2022
1	Cell Surface ReceptorsIBA 02/2022
1	Angiotensin-Converting Enzyme 2IBA 02/2022
1	Neuropilin-1IBA 02/2022
1	Ad26COVS1IBA 02/2022
1	Coenzyme A (CoA)IBA 02/2022
1	Oxidoreductases (Dehydrogenase)IBA 02/2022
1	AdipokinesIBA 12/2021
1	Tenecteplase FDA Link 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	SynucleinsIBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021
1	Dimethyl FumarateIBA 10/2017
1	Antihypertensive Agents (Antihypertensives)IBA 01/2017
1	Glial Fibrillary Acidic ProteinIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2016
1	AnticoagulantsIBA 09/2016
1	RivaroxabanIBA 09/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	Natalizumab (Tysabri)FDA Link 01/2016
1	IronIBA 01/2016
1	nitazoxanide (NTZ)FDA Link 01/2016
1	N-benzoyl-N-phenylhydroxylamineIBA 01/2016
1	Propylthiouracil FDA Link 08/2015
1	Thyroid HormonesIBA 08/2015
1	U 74389FIBA 07/2015
1	InterleukinsIBA 07/2015
1	Cholinergic ReceptorsIBA 06/2014

Therapy/Procedure

14	Therapeutics 03/2024 - 05/2014
2	Thrombectomy 01/2021 - 09/2019
2	Secondary Prevention 11/2020 - 09/2016
1	Precision Medicine 01/2023
1	Immunotherapy 01/2023
1	Duration of Therapy 01/2015
1	Stents 01/2015